HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria,and ...

Big pharmaceutical companies are boosting their production capacity of branded medications with billions of dollars in new U.S. manufacturing plant construction, but generic drug production still ...

The use of AI in healthcare is rapidly growing, but physicians are often left out of the conversation about how these technologies should be implemented effectively. That’s why the American Medical ...

More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...

We are only two weeks into 2025, and a small handful of healthcare AI companies have already announced funding rounds exceeding $100 million — signaling a strong start to what investors predicted ...

The FDA has approved a pill version of Novo Nordisk’s blockbuster drug Wegovy, giving the company the lead in the pharmaceutical industry pursuit of oral weight loss drugs while also providing ...

About 28% of American adults say it’s difficult to afford their prescription drugs, and the U.S. spends more on drugs than any peer nation, according to KFF. So who is responsible? According to Merith ...

Virtual and hybrid therapy companies are expanding rapidly amid persistently high demand levels for mental health services. On Tuesday, mental health care provider SonderMind participated in this ...

The concept of an antibody drug conjugate is straightforward enough: a cancer-killing drug payload attached to a targeting antibody that directs the molecule to cancer cells. Though these targeted ...

CMS has been trying to scale value-based care for decades with mixed results — but the agency’s newly announced ACCESS model could represent a more meaningful step toward aligning payment with ...

Contraline — a trailblazer in the nascent male contraceptive market — released promising new trial data on Thursday showing that the company’s contraceptive hydrogel has demonstrated safety and ...

Eli Lilly signaled its growing interest in genetic medicines for cardiovascular conditions when it partnered with Verve Therapeutics earlier this year, committing to share in development of a ...